The UroLift System is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men 50 years of age or older.
The UroLift System should not be used if you have:
Most patients do not typically require a catheter post-procedure, but it is possible that you may. If needed, the catheter typically only stays in for an average of about one day.1,2
Recovery times vary but patients typically experience rapid symptom relief and a return to normal activity within a few days.2 Your doctor will discuss any restrictions in your specific situation.
Most common side effects are temporary and can include discomfort when urinating, urgency, inability to control the urge, pelvic pain, and some blood in the urine.1 Rare side effects, including bleeding infection, may lead to a serious outcome and may require intervention.
See the UroLift System Instructions for Use for more information.
In the large, pivotal study, there were no reported instances of new, sustained erectile or ejaculatory dysfunction following a UroLift System procedure.3-5
Non-clinical testing has demonstrated that the UroLift Implant is MR Conditional. That means that you can be safely scanned in an MR system meeting the following conditions6:
Under the scan conditions defined above, the UroLift Implant is expected to produce a maximum temperature rise of 2.4°C after 15 minutes of continuous scanning (i.e., per pulse sequence).
In non-clinical testing, the image artifact caused by the device extends approximately 15 mm from the UroLift Implant when imaged with a gradient echo pulse sequence and a 3.0 Tesla MRI system.6
If you have any questions about MRI safety, please consult your doctor.